16.02
-0.04
(-0.22%)
As of 8:01:10 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 17 |
| Avg. Estimate | 1.89B | 1.94B | 7.83B | 8.17B |
| Low Estimate | 1.86B | 1.9B | 7.53B | 6.27B |
| High Estimate | 1.91B | 1.98B | 7.96B | 8.42B |
| Year Ago Sales | 1.75B | 1.8B | 7.38B | 7.83B |
| Sales Growth (year/est) | 7.70% | 7.74% | 6.08% | 4.32% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HU3.F | -- | -- | -- | -- |
| S&P 500 | 9.57% | 11.22% | 13.97% | 13.57% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Underweight to Underweight | 1/21/2025 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 1/21/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/21/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/21/2025 |
| Initiated | Truist Securities: Buy | 1/7/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 1/6/2025 |